Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

7.100 -0.020 (-0.28%)
Official Closing Price Updated: 7:00 PM EDT, Jun 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,166,009
Open 7.090
Bid (Size) 7.020 (71)
Ask (Size) 7.190 (10)
Prev. Close 7.120
Today's Range 6.970 - 7.200
52wk Range 4.000 - 10.23
Shares Outstanding 358,808,755
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq. 
Via Benzinga
Why Bausch Health Companies Stock Is Tanking Today
The never-ending saga over generic Xifaxan is weighing on the drugmaker's stock today. 
Via The Motley Fool

Performance

YTD
+13.06%
+13.06%
1 Month
+21.16%
+21.16%
3 Month
-14.66%
-14.66%
6 Month
-6.70%
-6.70%
1 Year
-21.11%
-21.11%

More News

Read More
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Why Shares of Bausch Health Soared Wednesday
Via The Motley Fool
Bausch Health Announces 2023 Annual Meeting of Shareholder Results
Via ACCESSWIRE
Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration
Via ACCESSWIRE
Zoetis Declares New Dividend, Hinting At Undervaluation
Via MarketBeat
Bausch Health Options Traders: Stock Will Remain Below This Level Through July Expiration
Via Benzinga
New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis
Via ACCESSWIRE
U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
Via ACCESSWIRE
Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023
Via ACCESSWIRE
Why Bausch Health Stock Is Tumbling Today
Via Benzinga
Bausch Health Observes Mental Health Awareness Month
Via ACCESSWIRE
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Recap: Bausch Health Companies Q1 Earnings
Via Benzinga
Bausch Health Announces First-Quarter 2023 Results
Via ACCESSWIRE
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel
Via ACCESSWIRE
Salix Partners with the Colorectal Cancer Alliance on Community Screening Program
Via ACCESSWIRE
US Stocks Set For Mixed Open As Banking Jitters Dampen Apple Earnings Buzz: Analyst Advises 'Cautious Optimism'
Via Benzinga
New Artificial Intelligence Tool Can Diagnose Colon Cancer
Via PressReach
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death Product Safety
Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value
Via Benzinga
Bausch Health to Announce First-Quarter 2023 Results on May 4
Via ACCESSWIRE
New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider
Via ACCESSWIRE
Bausch Health Announces Changes to its Board of Directors
Via ACCESSWIRE
Bausch Health's (BHC) Q4 Earnings & Sales Beat, Shares Up
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.